U.S. Compounding Inc., a subsidiary of DMK Pharmaceuticals Corp., pleaded guilty to multiple fraud offenses that violated the Food, Drug, and Cosmetic Act, the Justice Department said Tuesday.
The company and a former executive Sam Glover allegedly falsified prescription orders by illegally entering into an arrangement with a veterinarian in which a sales representative would use the veterinary state licenses to generate false prescriptions in order to justify shipping prescriptions directly to consumers. The consumers lacked bona fide prescriptions for those drugs, the DOJ said.
Despite scrutiny by members of the company who suspected the orders were unverified, the ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.